← Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
Revenue Segmentation by Product
Switch to Location
Fiscal year | Segment | Value |
---|---|---|
2024 | Duodopa | 447M |
2024 | Lumigan/Ganfort | 429M |
2024 | Imbruvica | 3.35B |
2024 | Vraylar | 3.27B |
